Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7237 results

Sort By:

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Study ID: NCT05929612
Start Date: 2023-07-28
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Ultra Low Dose 4 Gy Radiation

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

Study ID: NCT05130801
Start Date: 2021-11-19
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

55

Intervention / Treatment

pHLIP® ICG NIRF imaging

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

Study ID: NCT06745895
Start Date: 2024-10-21
End Date: 2028-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

350

Intervention / Treatment

MATCHES

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Study of NEO-201 in Solid Tumors Expansion Cohorts

Study ID: NCT03476681
Start Date: 2019-01-18
End Date: 2029-01-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

121

Intervention / Treatment

NEO-201 in combination with pembrolizumab

Sponsor

Precision Biologics, Inc

Source: clinicaltrials.gov

Share:
Add to list

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

Study ID: NCT06111781
Start Date: 2024-04-15
End Date: 2028-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Relugolix 120 MG [Orgovyx]

SBRT standard of care radiotherapy treatment

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Sexual Health in Breast Cancer Patients

Study ID: NCT05138510
Start Date: 2020-12-01
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

Focus Group

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Study ID: NCT06246110
Start Date: 2024-02-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Eik1001

Pembrolizumab

Paclitaxel

Pemetrexed

Carboplatin

Sponsor

Eikon Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)

Study ID: NCT05299710
Start Date: 2018-05-29
End Date: 2035-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment

Laparoscopic surgery

Sponsor

Erin Rowell

Source: clinicaltrials.gov

Share:
Add to list

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Study ID: NCT06516510
Start Date: 2024-10-31
End Date: 2026-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

24

Intervention / Treatment

Lutetium (177lu) RHPSMA 10.1 and MVLICTO®

Sponsor

Blue Earth Therapeutics Ltd

Source: clinicaltrials.gov

Share:
Add to list

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC)

Study ID: NCT05003895
Start Date: 2021-12-08
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

38

Intervention / Treatment

Cyclophosphamide

CAR-T cell

Fludarabine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list